| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.710 | 6.793 | 6.656 | 7.472 | 7.368 | 6.208 | 9.382 | 7.914 | 9.700 | 9.589 |
| Total Income - EUR | 7.710 | 6.793 | 10.559 | 7.472 | 7.368 | 6.208 | 9.382 | 8.277 | 9.700 | 9.589 |
| Total Expenses - EUR | 7.463 | 3.283 | 9.757 | 6.500 | 6.406 | 5.394 | 7.488 | 8.397 | 9.336 | 9.056 |
| Gross Profit/Loss - EUR | 247 | 3.510 | 802 | 972 | 962 | 815 | 1.895 | -121 | 364 | 533 |
| Net Profit/Loss - EUR | 16 | 3.306 | 485 | 748 | 741 | 680 | 1.765 | -335 | 271 | 456 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Avaviri - Prod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.640 | 7.268 | 5.841 | 6.244 | 6.880 | 7.377 | 9.058 | 8.691 | 8.917 | 9.638 |
| Inventories | 2.640 | 7.267 | 3.079 | 2.512 | 2.607 | 2.801 | 1.543 | 1.181 | 465 | 3.700 |
| Receivables | 0 | 0 | 2.756 | 0 | 0 | 7 | 0 | 0 | 54 | 139 |
| Cash | 0 | 0 | 6 | 3.732 | 4.273 | 4.569 | 7.514 | 7.509 | 8.398 | 5.800 |
| Shareholders Funds | 1.874 | 5.161 | 5.559 | 6.205 | 6.826 | 7.377 | 8.979 | 8.672 | 8.917 | 9.324 |
| Social Capital | 48 | 48 | 47 | 46 | 45 | 44 | 43 | 44 | 43 | 43 |
| Debts | 765 | 2.106 | 281 | 39 | 54 | 0 | 78 | 18 | 0 | 314 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Avaviri - Prod S.r.l.